Back to search
FDAFDA · Food and drugs·Recall number D-308-2013

Preservative-Free MORPHINE Sulfate Injection, USP, 10 mg/10 mL (1 mg/mL) 10 mL vial, Rx only, HOSPIRA, INC, LAKE FOREST, IL 60045 USA NDC 0409-3815-12

Published May 8, 2013 · Recall initiated: August 28, 2012

Summary

FDA records drug Class II recall D-308-2013, published May 8, 2013 and initiated August 28, 2012. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 26,100 vials; Lot: Lot 15-065-DK, Exp 1SEP2013. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial

What to do

Voluntary: Firm initiated · Letter

Get an email if MORPHINE SULFATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
MORPHINE SULFATE
Manufacturer
Hospira Inc.
Distributor
Nationwide and Puerto Rico
Lot
Lot 15-065-DK, Exp 1SEP2013
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Preservative-Free MORPHINE Sulfate Injection, USP, 10 mg/10 mL (1 mg/mL) 10 mL vial, Rx only, HOSPIRA, INC, LAKE FOREST, IL 60045 USA NDC 0409-3815-12 recalled?

Yes. FDA published recall D-308-2013 on May 8, 2013. Reported hazard: Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: MORPHINE SULFATE.